INTRODUCTION:
The development of clinical practice guidelines (CPGs) has increased; this study aimed to assess the quality of CPGs for the management of Chagas disease.
METHODS:
Following a systematic search of the scientific literature, two reviewers assessed the eligible guidelines using the Appraisal of Guidelines Research and Evaluation (AGREE) II instrument.
RESULTS:
Five CPGs were included. The AGREE domains of scope/purpose, stakeholder involvement, and clarity of presentation were rated well, and the domains of applicability and editorial independence received poor ratings.
CONCLUSIONS:
The quality of CPGs for Chagas disease is poor, and significant work is required to develop high-quality guidelines.
Chagas disease; Clinical Practice Guidelines; AGREE